Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Infections Post Transplant

Incidence and outcome of vancomycin-resistant enterococcal bacteremia following autologous peripheral blood stem cell transplantation

Bone Marrow Transplantation volume 25, pages 147–152 (2000)Cite this article

Abstract

A retrospective evaluation of 321 consecutive recipients of high-dose chemotherapy (HDC) and autologous peripheral blood stem cell transplantation (PBSCT) was conducted to ascertain the incidence and outcome of vancomycin-resistant enterococcal (VRE) bacteremia. Ten patients developed VRE bacteremia at a median of 6 days following PBSCT. Nine isolates were Enterococcus faecium and one was E. faecalis. The median duration of bacteremia was 5 days. The central venous catheter was removed in seven individuals. Nine patients were treated with a variety of antimicrobial agents including quinupristin-dalfopristin, chloramphenicol, doxycycline, oral bacitracin, co-trimoxazole, and nitrofurantoin. Bacteremia resolved without adverse sequelae in seven patients. Two individuals who died of other causes had persistent or relapsed bacteremia at the time of death. An additional patient suffered multiple relapses of VRE bacteremia and died as a result of VRE endocarditis 605 days following PBSCT. Mortality as a direct result of VRE bacteremia was 10% in this series. The optimal type and duration of treatment of VRE bacteremia has not been clearly defined. Therefore, we perform weekly stool surveillance cultures for VRE in our hospitalized transplant population and apply strict barrier precautions in those individuals in whom stool colonization has been identified. Furthermore, the empiric use of vancomycin has been restricted. Bone Marrow Transplantation (2000) 25, 147–152.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Englehard D, Monks MI, Good RAE . Infections in bone marrow transplant recipients J Pediatr 1986 108: 335–346

    Article  Google Scholar 

  2. Walter EA, Bowden RA . Infections in the bone marrow transplant recipient Infect Dis Clin North Am 1995 4: 823–847

    Google Scholar 

  3. Bilgrami S, Feingold JM, Dorsky D et al. Streptococcus viridans bacteremia following autologous peripheral blood stem cell transplantation Bone Marrow Transplant 1998 21: 591–595

    Article  CAS  Google Scholar 

  4. Schaberg DR, Culver DH, Gaynes RP . Major trends in microbial etiology of nosocomial infection Am J Med 1991 91: (Suppl.3B) 72S-75S

    Article  Google Scholar 

  5. Morris JG Jr, Shay DK, Hebden JN et al. Enterococci resistant to multiple antimicrobial agents, including vancomycin. Establishment of endemicity in a university medical center Ann Intern Med 1995 123: 250–259

    Article  Google Scholar 

  6. Wade JJ, Rolando N, Hayllar K et al. Bacterial and fungal infections after liver transplantation: an analysis of 284 patients Hepatology 1995 21: 1328–1336

    Article  CAS  Google Scholar 

  7. Chakraborty NG, Bilgrami S, Maness LJ et al. Myeloablative chemotherapy with autologous peripheral blood stem cell transplantation for metastatic breast cancer: immunologic consequences affecting clinical outcome Bone Marrow Transplant 1999 24: 837–843

    Article  CAS  Google Scholar 

  8. National Committee for Clinical Laboratory Procedures . Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, 3d edn National Committee for Clinical Laboratory Standards: Villanova, PA 1993

    Google Scholar 

  9. National Committee for Clinical Laboratory Procedures . Performance Standards for Antimicrobial Disk Susceptibility Tests, 5th edn National Committee for Clinical Laboratory Standards: Villanova, PA 1993

    Google Scholar 

  10. Jett BD, Huycke MM, Gilmore MS . Virulence of enterococci Clin Microbiol Rev 1994 7: 462–478

    Article  CAS  Google Scholar 

  11. Murray BE . The life and times of enterococcus Clin Microbiol Rev 1990 3: 46–65

    Article  CAS  Google Scholar 

  12. Clark NC, Cooksey RC, Hill BC et al. Characterization of glycopeptide-resistant enterococci from US hospitals Antimicrob Agents Chemother 1993 37: 2311–2317

    Article  CAS  Google Scholar 

  13. Chadwick PR, Oppenheim BA, Fox A et al. Epidemiology of an outbreak due to glycopeptide-resistant Enterococcus faecium on a leukemia unit J Hosp Infect 1996 34: 171–182

    Article  CAS  Google Scholar 

  14. Papanicolaou GA, Meyers BR, Meyers J et al. Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: risk factors for acquisition and mortality Clin Infect Dis 1996 23: 760–766

    Article  CAS  Google Scholar 

  15. Spera RV Jr, Farber BF . Multiply-resistant Enterococcus faecium. The nosocomial pathogen of the 1990s JAMA 1992 268: 2563–2564

    Article  Google Scholar 

  16. Montecalvo MA, Horowitz H, Gedris C et al. Outbreak of vancomycin-, ampicllin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit Antimicrob Agents Chemother 1994 38: 1363–1367

    Article  CAS  Google Scholar 

  17. Edmond MB, Ober JF, Weinbaum DL et al. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection Clin Infect Dis 1995 20: 1126–1133

    Article  CAS  Google Scholar 

  18. Patterson JE, Sweeny AH, Simms M et al. An analysis of 110 serious enteroccoccal infections Medicine 1995 75: 191–200

    Article  Google Scholar 

  19. Linden PK, Pasculle AW, Manez R et al . Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium Clin Infect Dis 1996 22: 663–670

    Article  CAS  Google Scholar 

  20. Elishoov H, Or R, Strauss N et al. Nosocomial colonization, septicemia, and Hickman/Broviac catheter-related infections in bone marrow transplantation recipients: a 5 year prospective study Medicine 1998 77: 83–101

    Article  CAS  Google Scholar 

  21. Tornieporth NG, Roberts RB, John J et al. Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients Clin Infect Dis 1996 23: 767–772

    Article  CAS  Google Scholar 

  22. Norris AH, Reilly JP, Edelstein PH et al. Chloramphenicol for the treatment of vancomycin-resistant enterococcal infections Clin Infect Dis 1995 20: 1137–1144

    Article  CAS  Google Scholar 

  23. Moreno F, Jorgensen JH, Weiner MH . An old antibiotic for a new multiple-resistant Enterococcus faecium Diagn Microbiol Infect Dis 1994 20: 41–43

    Article  CAS  Google Scholar 

  24. Moellering RC Jr . Vancomycin-resistant enterococci Clin Infect Dis 1998 26: 1196–1199

    Article  Google Scholar 

  25. Chia JKS, Nakata MM, Park SS et al. Use of bacitracin therapy for infection due to vancomycin-resistant Enterococcus faecium Clin Infect Dis 1995 21: 1520 (letter)

    Article  Google Scholar 

  26. O'Donovan CA, Fan-Havard P, Tecson-Tumang FT et al. Enteric eradication of vancomycin-resistant Enterococcus faecium with oral bacitracin Diagn Microbiol Infect Dis 1994 18: 105–109

    Article  CAS  Google Scholar 

  27. Lai KK . Treatment of vancomycin-resistant Enterococcus faecium infections Arch Intern Med 1996 156: 2579–2584

    Article  CAS  Google Scholar 

  28. Eliopoulos GM, Wennersten CB, Gold HS et al. Characterization of vancomycin-resistant Enterococcus faecium isolates from the United States and their susceptibility in vitro to dalfopristin-quinupristin Antimicrob Agents Chemother 1998 42: 1088–1092

    Article  CAS  Google Scholar 

  29. Centers for Disease Control and Prevention Nosocomial enterococci resistant to vancomycin – United States 1989–1993 Morb Mortal Wkly Rep 1993 42: 597–599

  30. Gregory JJ, Small TN, Papadopoulos E et al. Influence of vancomycin-resistant enterococcus on the outcome of recipients of bone marrow transplants Proc Am Soc Clin Oncol 1999 18: 51a (Abstr.)

    Google Scholar 

  31. Noskins GA, Stosor V, Cooper I, Peterson LR . Recovery of vancomycin-resistant enterococci on fingertips and environmental surfaces Infect Control Hosp Epidemiol 1995 16: 577–581

    Article  Google Scholar 

  32. Rhinehart E, Smith NE, Wennersten C et al. Rapid dissemination of B-lactamase-producing, aminoglycocide-resistant Enterococcus faecalis among patients and staff of an infant-toddler surgical ward New Engl J Med 1990 323: 1814–1818

    Article  CAS  Google Scholar 

  33. Karanfil LV, Murphy M, Josephson A et al. A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit Infect Control Hosp Epidemiol 1992 13: 195–200

    Article  CAS  Google Scholar 

  34. Livornese LL Jr, Dias S, Samel C et al. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers Ann Intern Med 1992 117: 112–116

    Article  Google Scholar 

  35. Boyce JM, Opal SM, Chow JW et al. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance J Clin Microbiol 1994 32: 1148–1153

    CAS  PubMed  PubMed Central  Google Scholar 

  36. Hospital Infection Control Practices Advisory Committee (HICPAC) . Recommendations for preventing the spread of vancomycin resistance Infect Control Hosp Epidemiol 1995 16: 105–113

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Bone Marrow Transplant Program, University of Connecticut Health Center, Farmington, CT, USA

    D Kapur, D Dorsky, JM Feingold, RD Bona, RL Edwards, J Aslanzadeh, PJ Tutschka & S Bilgrami

Authors
  1. D Kapur
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D Dorsky
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. JM Feingold
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. RD Bona
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. RL Edwards
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J Aslanzadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. PJ Tutschka
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. S Bilgrami
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kapur, D., Dorsky, D., Feingold, J. et al. Incidence and outcome of vancomycin-resistant enterococcal bacteremia following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 25, 147–152 (2000). https://doi.org/10.1038/sj.bmt.1702123

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702123

Keywords

This article is cited by

Search

Advanced search

Quick links